CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
Grant income	$ 0	$ 195,874	$ 0	$ 530,106
Operating Expenses:
Research and development	7,182,099	3,969,070	17,818,373	12,680,430
General and administrative	3,274,480	3,192,403	9,902,120	8,389,821
Total operating expenses	10,456,579	7,161,473	27,720,493	21,070,251
Operating loss	(10,456,579)	(6,965,599)	(27,720,493)	(20,540,145)
Other (expense) income	(8,213)	(1,845)	(8,213)	(38,741)
Loss on derivative instruments	1,116,619	(1,282,829)	(991,562)	(3,565,347)
Warrant inducement expense	0	(805,753)	0	805,753
Other non-operating gains	761,237	(950,935)	1,436,473	774,245
Interest expense, net	(351,332)	(273,708)	(872,457)	(777,898)
Net loss	(8,938,268)	(10,276,979)	(28,156,252)	(24,876,157)
Modification of warrants	(265,082)	0	(350,861)	(21,734)
Net loss available to common shareholders	$ (9,203,350)	$ (10,276,979)	$ (28,507,113)	$ (24,897,891)
Net loss per common share - basic	$ (0.22)	$ (0.27)	$ (0.71)	$ (0.69)
Weighted average common shares outstanding - basic	41,020,485	37,453,539	39,907,624	36,230,992
Net loss per common share - diluted	$ (0.25)	$ (0.27)	$ (0.74)	$ (0.69)
Weighted average common shares outstanding - diluted	41,231,082	37,453,539	40,158,321	36,230,092